American Journal of Infection Control

Material resources during public health emergencies may be restricted and the processing of personal protective equipment such as Filtering Facepiece Respirators (FFRs) for N95 filtering or higher may be placed on the agenda1. Thus, health services

The topic of the Journal Club commentary is the article “Stopping the routine use of contact precautions for management of Methicillin-Resistant Staphylococcus aureus (MRSA) and Vancomycin-Resistant Enterococcus (VRE) at 3 academic medical centers

Update existing meta-analysis to analyze if discontinuation of contact precautions (CPs) for Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin resistant Enterococcus (VRE) colonization or infection affects hospital-associated MRSA or

The human skin is the largest immune organ and plays countless roles in maintaining health1. One critical role is the prevention of infection. There are several proposed mechanisms underlying the skin's capacity to prevent infection, one of which is

: Identify research gaps relevant to the global effort to combat antimicrobial resistance.

The novel Coronavirus, SARS-CoV-2, and subsequent COVID-19 pandemic has led to a public health crisis.1,2 In the United States, the COVID-19 outbreak has had profound economic and social impact as a result of statewide quarantines, social distancing

Preventing healthcare-associated infections continues to be a major focus for healthcare systems. Whereas there are numerous evidence-based infection prevention practices published in national guidelines, such as device insertion and maintenance

Indwelling urinary catheters are often placed in patients undergoing surgery, especially if surgery time is prolonged, to facilitate intraoperative monitoring of urinary output.1,2 Yet, use of indwelling urinary catheters introduces risk for

Central line-associated bloodstream infections (CLABSI) occurring in intensive care units are associated with increased morbidity and mortality.1-3 These infections increase the length of hospital stay for an affected patient, as well as the cost of

COVID-19 has spread quickly: worldwide, as of November 6, 2020, there were 48,196,862 total cases, with 1,226,813 total deaths.1 Because there are currently no approved vaccines and few broadly applicable proven effective treatments for COVID-19, the